SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-011829
Filing Date
2017-11-27
Accepted
2017-11-27 16:15:18
Documents
63
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q optinose09-30x201710xq.htm 10-Q 711971
2 EXHIBIT 31.1 optinose09-30x201710xqex311.htm EX-31.1 9636
3 EXHIBIT 31.2 optinose09-30x201710xqex312.htm EX-31.2 9561
4 EXHIBIT 32.1 optinose09-30x201710xqex321.htm EX-32.1 7064
5 EXHIBIT 32.2 optinose09-30x201710xqex322.htm EX-32.2 7092
12 optinoselogorgba02.jpg GRAPHIC 10067
  Complete submission text file 0001628280-17-011829.txt   4325125

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT optn-20170930.xml EX-101.INS 711265
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20170930.xsd EX-101.SCH 34425
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT optn-20170930_cal.xml EX-101.CAL 60906
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT optn-20170930_def.xml EX-101.DEF 267873
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20170930_lab.xml EX-101.LAB 494122
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20170930_pre.xml EX-101.PRE 346956
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38241 | Film No.: 171223066
SIC: 2834 Pharmaceutical Preparations